Cargando…
Mega randomized clinical trials: a definitive solution or a double-edged sword?
Autores principales: | Lemaitre, Florian, Laviolle, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516089/ https://www.ncbi.nlm.nih.gov/pubmed/34651199 http://dx.doi.org/10.1007/s00228-021-03230-w |
Ejemplares similares
-
Autophagy, a double-edged sword in hepatocarcinogenesis
por: Tian, Yongjun, et al.
Publicado: (2015) -
The double-edge sword effect of anti-CD73 cancer therapy
por: Stagg, John
Publicado: (2012) -
Non-coding RNAs, the cutting edge of histone messages
por: Köhn, Marcel, et al.
Publicado: (2016) -
Maximizing the value of the open label extension phase of randomized clinical trials
por: Trachtman, Howard, et al.
Publicado: (2023) -
Signaling via MYD88 in the pancreatic tumor microenvironment: A double-edged sword
por: Zambirinis, Constantinos P., et al.
Publicado: (2013)